• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄连益智汤通过干扰 Aβ-tau 的神经毒性相互作用改善 APP/PS1/tau 三转基因小鼠的认知缺陷。

Huannao Yicong decoction ameliorates cognitive deficits in APP/PS1/tau triple transgenic mice by interfering with neurotoxic interaction of Aβ-tau.

机构信息

Institute of Geriatrics, Xiyuan Hospital, China Academy of Chinese Medical Sciences, 1 Xiyuan Caochang Road, Haidian District, Beijing, 100091, China.

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, No. 11 North Third Ring Road East, Chaoyang District, Beijing, 100029, China.

出版信息

J Ethnopharmacol. 2024 Jan 10;318(Pt B):116985. doi: 10.1016/j.jep.2023.116985. Epub 2023 Aug 1.

DOI:10.1016/j.jep.2023.116985
PMID:37532075
Abstract

ETHNOPHARMACOLOGICAL RELEVANCE

Huannao Yicong decoction (HYD) has been used in the study of AD for many years, which consists of Polygonum multiflorum Thunb., Panax ginseng C.A.Mey., Acorus gramineus Aiton, Coptis chinensis Franch., and Conioselinum acuminatum (Franch.) Lavrova. Previous studies have found that HYD could reduce β-Amyloid (Aβ) deposition and tau hyperphosphorylation which are the two critical pathological factors of AD. However, the mechanism of the neurotoxic interaction between Aβ and tau in AD remains unclear. Thus, the underlying mechanisms for HYD improving cognitive function of AD by interfering with the neurotoxic interaction between Aβ and tau remain to be explored.

AIM OF THE STUDY

The main objective of this study is to clarify the specific mechanisms of HYD on interfering with the neurotoxic interaction between Aβ and tau of AD both in vivo and in vitro.

MATERIALS AND METHODS

APP/PS1/tau triple transgenic mice were randomly divided into 4 groups, namely model group, memantine group, HYD low-dose group (HYD-L), and HYD high-dose group (HYD-H) with 28 mice in each group, while 28 C57BL/6J mice as the control group. Gavage was applied to all the mice daily for 24 weeks. SH-SY5Y model cells overexpressing Aβ and tau proteins as the intervention object in vitro experiments. Morris water maze was used to observe the learning and memory ability of APP/PS1/tau mice. Aβ deposition was detected by immunohistochemistry, and the levels of Aβ and Aβ were detected by enzyme-linked immunosorbent assay (ELISA). Neurofibrillary tangles (NFTs) were observed by silver staining and the levels of phosphorylated tau proteins were detected by Western blot. The GSK-3β and CDK-5 mRNA expression were detected by real-time polymerase chain reaction (RT-PCR). Besides, the levels of PSD95, GluR1, NR2A, and NR2B were detected by Western blot. Meanwhile, cell experiments were performed to further verify the effect of HYD on tau phosphorylation related kinases (GSK-3β, CDK-5, and PP2A), which further to clarify the mechanism of HYD intervention on the neurotoxic interaction between Aβ and tau.

RESULTS

HYD improved the learning and memory ability of APP/PS1/tau mice. HYD decreased the levels of Aβ and Aβ inhibited tau hyperphosphorylation, which reduced Aβ deposition and NFTs forming. In addition, HYD inhibited the activity of kinases GSK-3β and CDK-5, and enhancing the activity of kinase PP2A. Moreover, HYD inhibited the overexpression of NR2A and NR2B, and increased the expression of GluR1 and postsynaptic density protein-95 (PSD95).

CONCLUSIONS

HYD can improve the cognitive deficits by interfering with the neurotoxic interaction between Aβ and tau. In addition, HYD can inhibit the overactivation of NMDARs and increase the levels of GluR1 and PSD95, which may play a role in alleviating neuronal excitotoxicity and improving synaptic function.

摘要

民族药理学相关性

还脑益聪方(HYD)多年来一直用于 AD 的研究,它由何首乌、人参、菖蒲、黄连和苍耳组成。先前的研究发现,HYD 可以减少β-淀粉样蛋白(Aβ)沉积和 tau 过度磷酸化,这是 AD 的两个关键病理因素。然而,AD 中 Aβ和 tau 之间神经毒性相互作用的机制仍不清楚。因此,HYD 通过干扰 Aβ和 tau 之间的神经毒性相互作用来改善 AD 认知功能的潜在机制仍有待探索。

研究目的

本研究的主要目的是阐明 HYD 体内、体外干预 AD 中 Aβ和 tau 之间神经毒性相互作用的具体机制。

材料和方法

APP/PS1/tau 三转基因小鼠随机分为 4 组,即模型组、美金刚组、HYD 低剂量组(HYD-L)和 HYD 高剂量组(HYD-H),每组 28 只,另设 28 只 C57BL/6J 小鼠为对照组。所有小鼠每日灌胃,共 24 周。体外实验以过表达 Aβ和 tau 蛋白的 SH-SY5Y 模型细胞为干预对象。Morris 水迷宫用于观察 APP/PS1/tau 小鼠的学习记忆能力。免疫组织化学法检测 Aβ 沉积,酶联免疫吸附试验(ELISA)检测 Aβ 和 Aβ。银染观察神经原纤维缠结(NFTs),Western blot 检测磷酸化 tau 蛋白水平。实时聚合酶链反应(RT-PCR)检测 GSK-3β 和 CDK-5 mRNA 表达。Western blot 检测 PSD95、GluR1、NR2A 和 NR2B 水平。同时,进行细胞实验进一步验证 HYD 对 tau 磷酸化相关激酶(GSK-3β、CDK-5 和 PP2A)的作用,进一步阐明 HYD 干预 Aβ 和 tau 之间神经毒性相互作用的机制。

结果

HYD 改善了 APP/PS1/tau 小鼠的学习记忆能力。HYD 降低了 Aβ 和 Aβ 的水平,抑制了 tau 过度磷酸化,减少了 Aβ 沉积和 NFTs 的形成。此外,HYD 抑制了激酶 GSK-3β 和 CDK-5 的活性,增强了激酶 PP2A 的活性。此外,HYD 抑制了 NMDARs 的过度激活,增加了 GluR1 和突触后密度蛋白-95(PSD95)的表达。

结论

HYD 可通过干扰 Aβ 和 tau 之间的神经毒性相互作用改善认知障碍。此外,HYD 可抑制 NMDARs 的过度激活,增加 GluR1 和 PSD95 的水平,从而可能减轻神经元兴奋性毒性和改善突触功能。

相似文献

1
Huannao Yicong decoction ameliorates cognitive deficits in APP/PS1/tau triple transgenic mice by interfering with neurotoxic interaction of Aβ-tau.黄连益智汤通过干扰 Aβ-tau 的神经毒性相互作用改善 APP/PS1/tau 三转基因小鼠的认知缺陷。
J Ethnopharmacol. 2024 Jan 10;318(Pt B):116985. doi: 10.1016/j.jep.2023.116985. Epub 2023 Aug 1.
2
HDAC6 modulates the cognitive behavioral function and hippocampal tissue pathological changes of APP/PS1 transgenic mice through HSP90-HSF1 pathway.组蛋白去乙酰化酶 6 通过热休克蛋白 90-热休克因子 1 通路调节 APP/PS1 转基因小鼠的认知行为功能和海马组织病理变化。
Exp Brain Res. 2024 Aug;242(8):1983-1998. doi: 10.1007/s00221-024-06858-z. Epub 2024 Jun 27.
3
GSK3β is involved in promoting Alzheimer's disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor protein knock-in mice.GSK3β 参与促进淀粉样前体蛋白敲入小鼠慢性全身暴露于牙龈卟啉单胞菌脂多糖后阿尔茨海默病的病理。
Brain Behav Immun. 2021 Nov;98:1-12. doi: 10.1016/j.bbi.2021.08.213. Epub 2021 Aug 13.
4
Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells.微小 RNA-137 抑制阿尔茨海默病中的 Tau 过度磷酸化,并在转基因小鼠和人神经母细胞瘤 SH-SY5Y 细胞中靶向 CACNA1C 基因。
Med Sci Monit. 2018 Aug 13;24:5635-5644. doi: 10.12659/MSM.908765.
5
Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study.复智散改善11月龄APP/PS1转基因小鼠海马区β淀粉样蛋白生成及tau蛋白磷酸化:蛋白质免疫印迹研究
Exp Gerontol. 2016 Nov;84:88-95. doi: 10.1016/j.exger.2016.09.003. Epub 2016 Sep 7.
6
Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice.阿托伐他汀可改善APP/PS1转基因小鼠的认知障碍、β淀粉样蛋白1-42生成及 Tau 蛋白过度磷酸化。
Metab Brain Dis. 2016 Jun;31(3):693-703. doi: 10.1007/s11011-016-9803-4. Epub 2016 Feb 16.
7
Huannao Yicong Decoction () extract reduces inflammation and cell apoptosis in Aβ-induced Alzheimer's disease model of rats.还脑益聪方提取物减轻Aβ诱导的大鼠阿尔茨海默病模型中的炎症和细胞凋亡。
Chin J Integr Med. 2017 Sep;23(9):672-680. doi: 10.1007/s11655-016-2255-1. Epub 2016 Mar 29.
8
L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.L-3-正丁基苯酞可降低 tau 磷酸化水平,改善 APP/PS1 阿尔茨海默病转基因小鼠的认知功能障碍。
J Alzheimers Dis. 2012;29(2):379-91. doi: 10.3233/JAD-2011-111577.
9
Potassium 2-(1-hydroxypentyl)-benzoate improves memory deficits and attenuates amyloid and τ pathologies in a mouse model of Alzheimer's disease.2-(1-羟戊基)苯甲酸钾改善阿尔茨海默病小鼠模型的记忆缺陷,并减轻淀粉样蛋白和τ病理。
J Pharmacol Exp Ther. 2014 Aug;350(2):361-74. doi: 10.1124/jpet.114.213140. Epub 2014 Jun 3.
10
Huannao Yicong Formula () regulates γ-secretase activity through APH-1 and PEN-2 gene ragulation pathways in hippocampus of APP/PS1 double transgenic mice.还脑益聪方通过调控APP/PS1双转基因小鼠海马中APH-1和PEN-2基因的途径来调节γ-分泌酶活性。
Chin J Integr Med. 2017 Apr;23(4):270-278. doi: 10.1007/s11655-017-2402-3. Epub 2017 Jan 24.

引用本文的文献

1
Top 100 most-cited articles on tau protein: a bibliometric analysis and evidence mapping.关于tau蛋白的100篇被引用次数最多的文章:文献计量分析与证据图谱
Front Neurosci. 2024 Jan 31;18:1345225. doi: 10.3389/fnins.2024.1345225. eCollection 2024.